Department of General Surgery, Hospital Universitario Son Espases, Palma de Mallorca, Spain.
Department of Pathological Anatomy, Hospital Universitario Son Espases, Palma de Mallorca, Spain.
Acta Chir Belg. 2022 Jun;122(3):204-210. doi: 10.1080/00015458.2020.1794334. Epub 2020 Jul 16.
Mesenteric fibromatosis is a benign locally-aggressive mesenchymal neoplasm that lacks the potential for metastasis. It is related to Gardner's Syndrome, previous trauma, abdominal surgery, and prolonged intake of oestrogen. Differentially diagnosing this from similar tumours is crucial in order for establishing the appropriate treatment and only immunohistochemical features can be used for a definitive diagnosis. Although medical therapies play a role in the treatment of mesenteric fibromatosis, surgical resection is the gold-standard procedure.
Our case study is a 40-year-old male with a concomitant diagnosis of non-Hodgkin lymphoma and mesenteric fibromatosis, not associated with any of the risk factors mentioned above. We performed CT and PET scans and observed a vascularised and well-defined mesenteric centre-abdominal hypermetabolic solid mass in contact with the gastric body, duodenum, body and tail of the pancreas, transverse colon, and spleen. An ultrasound-guided tru-cut biopsy revealed features suggestive of mesenteric fibromatosis.
An elective laparotomy was carried out and a giant mass, arising from mesentery, was excised, including a partial gastrectomy and segmental resection of the transverse colon. Distal pancreatectomy, small bowel resection and successive splenectomy were performed due to a large hypertensive component. The postoperative period was uneventful. The histopathology of the surgical pieces was compatible with intra-abdominal desmoid fibromatosis.
As far as we know from the literature, this is the largest mesenteric fibromatosis tumour ever to be excised. We also noticed that this is the first reported case of the concomitant presence of mesenteric fibromatosis and non-Hodgkin lymphoma that is not related to any of the described risk factors. Further research is needed to establish what type of association this presentation may indicate.
肠系膜纤维瘤病是一种良性局部侵袭性间叶性肿瘤,缺乏转移潜能。它与 Gardner 综合征、既往外伤、腹部手术和长期雌激素摄入有关。为了确定适当的治疗方法,将其与类似肿瘤区分开来至关重要,只有免疫组织化学特征可用于明确诊断。尽管医学治疗在肠系膜纤维瘤病的治疗中发挥作用,但手术切除是金标准。
我们的病例研究是一名 40 岁男性,同时患有非霍奇金淋巴瘤和肠系膜纤维瘤病,但与上述任何危险因素均无关。我们进行了 CT 和 PET 扫描,观察到一个血管化和边界清晰的肠系膜中心-腹部高代谢实性肿块,与胃体、十二指肠、胰体和尾、横结肠和脾脏接触。超声引导 tru-cut 活检显示出肠系膜纤维瘤病的特征。
进行了择期剖腹手术,切除了起源于肠系膜的巨大肿块,包括部分胃切除术和横结肠节段切除术。由于存在较大的高血压成分,进行了胰头切除术、小肠切除术和连续脾切除术。术后恢复顺利。手术标本的组织病理学与腹内纤维瘤病相符。
据我们从文献中了解到,这是切除的最大肠系膜纤维瘤病肿瘤。我们还注意到,这是首例同时存在肠系膜纤维瘤病和非霍奇金淋巴瘤的报告病例,且与任何已描述的危险因素均无关。需要进一步研究以确定这种表现可能表明何种关联。